Recombinant spider silk particles as drug delivery vehicles
โ Scribed by Andreas Lammel; Martin Schwab; Markus Hofer; Gerhard Winter; Thomas Scheibel
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 965 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0142-9612
No coin nor oath required. For personal study only.
โฆ Synopsis
Spider silk has been in the focus of research mainly due to the superior mechanical characteristics of silk fibers. However, it has been previously shown that spider silk proteins can also adopt other morphologies such as submicroparticles. This study examines the applicability of such particles as drug carriers. Particle characterization revealed that particles made of the engineered spider silk protein eADF4(C16) are colloidally stable in solution. Here, it is shown that small molecules with positive net-charge can diffuse into the negatively charged spider silk protein matrix driven by electrostatic interactions. The loading efficiencies correlate with the distribution coefficient (logD) of small molecules of weak alkaline nature. Interestingly, constant release rates can be realized for a period of two weeks at physiological conditions in vitro, with accelerated release rates within acidic environments. Enzymatic degradation studies of eADF4(C16) particles indicated that the silk proteins degrade slowly and the particles decrease in size. Along with their all-aqueous and easy preparation, drug loaded eADF4(C16) particles provide a high potential for diverse applications in which controlled release from biodegradable carriers is desired.
๐ SIMILAR VOLUMES
The past decade has been witness to a new impetus in surfactant self-assembly objects as agents for drug delivery that are an alternative to micellar, lamellar (liposome, niosome and transfersome) or microemulsion-based vehicles. The review focus herein is on the application of hexagonal, cubic, 'in
## Abstract New delivery approaches to achieve minimally invasive, sustained and local release of drugs are needed for more effective treatment of conditions such as cancer and ischemia. Hydrophobic, biodegradable, liquid injectable polymers possess a number of potential advantages for this purpose